| CleanSpace Holdings Limited (CSX) ORDINARY FULLY PAID |
Health Care |
$31 |
FY25 Results Announcement
|
26 Aug 2025 9:16AM |
$0.815 |
$0.395 |
fallen by
51.53%
|
|
CSX - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 results show revenue growth and improved core market sales
- Continued investment in product development and innovation
- Expansion efforts in new international sectors and markets
- Maintained profitability despite economic and supply chain challenges
- Strengthened cash position and operational efficiency
- Strategic focus on customer needs and sustainability initiatives
- Emphasis on worker safety and respiratory protection solutions
- Outlook includes further international expansion and efficiency improvements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adavale Resources Limited (ADD) ORDINARY FULLY PAID |
Materials |
$14 |
Drill Target Definition Advancing at Ashes Prospect
|
26 Aug 2025 9:16AM |
$0.027 |
$0.039 |
risen by
44.44%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$38 |
Appendix 4E and 30 June 2025 Annual Report to shareholders
|
26 Aug 2025 9:15AM |
$0.605 |
$0.725 |
risen by
19.83%
|
|
KME - Price-sensitive ASX Announcement
Full Release
Key Points
- Kip McGrath Education Centres Limited (KME) released its Appendix 4E and Annual Report for the year ended 30 June 2025.
- KME achieved a 13% increase in revenue to $31.1m, driven by growth in both franchise and company-owned centres.
- EBITDA increased by 17% to $11.3m, reflecting improved operating margins.
- Net profit after tax was $5.3m, an increase of 12% compared to the previous year.
- The company’s strategic focus included expanding its global network, enhancing digital tutoring platforms, and investing in marketing and technology.
- KME maintained a strong balance sheet with cash reserves and minimal debt.
- A final fully franked dividend of 3.5 cents per share was declared, bringing the total dividends for the year to 6.5 cents per share.
- The Chairman’s and CEO’s reports highlighted robust student demand, effective cost management, and continued growth prospects.
- KME’s risk management framework was strengthened, with ongoing attention to regulatory compliance, cybersecurity, and franchise support.
- The report outlined corporate governance practices, board composition, and remuneration policies.
- KME remains committed to educational outcomes, innovation, and supporting franchise partners.
- The outlook for FY26 is positive, with continued investment in technology, new centre openings, and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Edge Limited (PEB) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$261 |
NZ RegCo Share Price Enquiry into Pacific Edge Limited
|
26 Aug 2025 9:15AM |
$0.130 |
$0.210 |
risen by
61.54%
|
|
| Carlton Investments Limited (CIN) ORDINARY FULLY PAID |
Financials |
$944 |
Daily share buy-back notice - Appendix 3E
|
26 Aug 2025 9:15AM |
$37.520 |
$35.850 |
fallen by
4.45%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$469 |
Tyro 2025 Corporate Governance Statement
|
26 Aug 2025 9:14AM |
$1.200 |
$0.880 |
fallen by
26.67%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$469 |
Tyro FY25 Appendix 4G
|
26 Aug 2025 9:14AM |
$1.200 |
$0.880 |
fallen by
26.67%
|
|
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$163 |
Reinstatement to Quotation
|
26 Aug 2025 9:14AM |
$0.620 |
$0.285 |
fallen by
54.03%
|
|
PEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Peninsula Energy Limited's securities to be reinstated to official quotation on the ASX.
- The reinstatement follows satisfaction of ASX's requirements after voluntary suspension.
- Trading of securities will recommence on a specific date and time as detailed in the announcement.
- The company confirms compliance with ASX Listing Rules.
- Contact details are provided for further information.
- Peninsula Energy affirms its commitment to regulatory compliance and transparent communication.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$469 |
Tyro FY25 Results Investor Presentation
|
26 Aug 2025 9:14AM |
$1.200 |
$0.880 |
fallen by
26.67%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported strong year-on-year growth in transaction value and revenue, with improved EBITDA margins.
- Expanded merchant base and continued focus on customer experience and retention.
- Leveraged proprietary technology platform to introduce new payments solutions and features.
- Forged strategic partnerships with financial institutions and technology providers to enhance service offerings.
- Maintained disciplined cost management while scaling operations and investing in innovation.
- Outlined FY25 financial guidance with expectations for continued revenue and earnings growth.
- Highlighted commitment to sustainable shareholder value creation and long-term strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$165 |
UCLA Health Activation & Continuous Innovation Study Update
|
26 Aug 2025 9:14AM |
$1.810 |
$1.770 |
fallen by
2.21%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- EMvision Medical Devices Limited (EMV) updates on UCLA Health Activation & Continuous Innovation Study.
- The study evaluates EMvision's portable brain imaging device in a real-world hospital setting.
- Collaboration with UCLA Health aims to assess workflow, usability, and device performance.
- Clinician and stakeholder feedback are central to refining the device and guiding commercial and regulatory strategies.
- Interim feedback is positive regarding device portability, ease of use, and integration into acute care.
- The device is being assessed in routine clinical workflows without interfering with standard patient care.
- Ongoing data collection and clinician engagement will inform further product development.
- The study is important for future regulatory submissions and commercial adoption.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) ORDINARY FULLY PAID |
Materials |
- |
5E Announces Closing of $8.31 Million Public Offering
|
26 Aug 2025 9:14AM |
$0.560 |
$0.250 |
fallen by
55.36%
|
|
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$163 |
Completion T1 Placement and Institutional Entitlement Offer
|
26 Aug 2025 9:14AM |
$0.620 |
$0.285 |
fallen by
54.03%
|
|
PEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Peninsula Energy Limited completed the Tranche 1 Placement and Institutional Entitlement Offer, raising A$48.3 million.
- Proceeds will be primarily used for the restart and ramp-up of operations at the Lance Projects in Wyoming, USA.
- Strong participation from both existing and new institutional investors in the capital raising.
- The capital raised will support production and working capital needs for the Ross and Kendrick production units.
- Further capital raising through Tranche 2 Placement and Retail Entitlement Offer is planned.
- Details of the allocation, timetable, and use of funds are provided.
- The initiative aligns with the company’s strategy to become a reliable uranium producer amid positive market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,430 |
Update - Notification of buy-back - AFI
|
26 Aug 2025 9:14AM |
$7.360 |
$6.870 |
fallen by
6.66%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$469 |
Tyro FY25 Results Media Release
|
26 Aug 2025 9:14AM |
$1.200 |
$0.880 |
fallen by
26.67%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Record transaction values and revenue for FY25.
- Improved profit margins and operational efficiency.
- Ongoing investment in digital infrastructure and innovation.
- Expanded product offerings to better serve merchant needs.
- Strategic initiatives focused on customer experience and competitive positioning.
- Emphasis on regulatory compliance and risk management.
- Sustainable growth targeted through operational excellence and technology advancements.
- Positive outlook for continued performance in the evolving payments sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chrysos Corporation Limited (C79) ORDINARY FULLY PAID |
Industrials |
$863 |
Full Year Results FY25
|
26 Aug 2025 9:13AM |
$6.600 |
$7.410 |
risen by
12.27%
|
|
C79 - Price-sensitive ASX Announcement
Full Release
Key Points
- Chrysos Corporation Limited (C79) reports FY24 full year results ending 30 June 2024.
- Significant growth in deployments of PhotonAssay units globally.
- Continued expansion in mining industry with new customers and geographies.
- Revenue and EBITDA improved over the previous year.
- Operational highlights include milestone achievements and enhanced service capability.
- Ongoing strategy focused on profitability, innovation, and global reach.
- Commitment to technology leadership and delivering stakeholder value.
- Disclosure on corporate governance, risk management, and future outlook.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$469 |
Tyro FY25 Annual Report
|
26 Aug 2025 9:13AM |
$1.200 |
$0.880 |
fallen by
26.67%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Tyro Payments Limited reported on its FY25 performance, emphasizing technology-driven solutions in merchant acquiring and banking.
- Revenue growth was achieved through expanded merchant relationships and continued investment in product innovation.
- The company prioritized operational efficiency and digital transformation to enhance customer experiences.
- Regulatory compliance and risk management remained important focus areas, with ongoing adaptation to the changing regulatory landscape.
- Tyro outlined its governance structure, board composition, and commitment to ethical business practices.
- The outlook for the future emphasizes sustainable growth, leveraging technology, and deepening market penetration.
- Strategic investments were made in digital infrastructure and product development to strengthen competitive positioning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blaze Minerals Limited (BLZ) ORDINARY FULLY PAID |
Energy |
$3 |
Loulombo Project Update
|
26 Aug 2025 9:13AM |
$0.004 |
$0.001 |
fallen by
75%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
26 Aug 2025 9:12AM |
$1.150 |
$1.240 |
risen by
7.83%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$80 |
Amplia Share Purchase Plan Raises $2.65 Million
|
26 Aug 2025 9:12AM |
$0.190 |
$0.155 |
fallen by
18.42%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited successfully completed a Share Purchase Plan (SPP), raising approximately $2.65 million.
- The SPP was strongly supported by existing shareholders, leading to an oversubscription.
- Applications to the SPP will be scaled back in accordance with the offer terms.
- Funds raised will be used to progress clinical development, particularly the ACCENT trial for AMP945 in pancreatic cancer.
- Additional use of funds includes general working capital.
- New shares issued under the SPP will rank equally with existing ordinary shares.
- The Board expressed gratitude to shareholders for their ongoing support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ballard Mining Limited (BM1) ORDINARY FULLY PAID |
Materials |
$203 |
High Grade Infill and Extensional Drill Results at Mt Ida
|
26 Aug 2025 9:12AM |
$0.445 |
$0.680 |
risen by
52.81%
|
|
BM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Ballard Mining Limited announced high-grade gold results from infill and extensional drilling at Mt Ida.
- Drilling targeted the Bald Hill and Meteor North prospects within the Mt Ida Gold Project.
- Significant intercepts include 12.9m @ 14.1g/t Au from 94.1m at Bald Hill.
- Results confirm continuity of high-grade mineralization and suggest potential for resource growth.
- Drilling demonstrates mineralization remains open along strike and at depth.
- The company plans further drilling to expand and upgrade the resource base.
- The results are considered strategically important for Ballard’s development plans at Mt Ida.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gladiator Resources Limited (GLA) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
26 Aug 2025 9:12AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
GLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Gladiator Resources Limited (ASX: GLA) requested a trading halt on 21 June 2024.
- The trading halt was requested pending an announcement about a capital raising.
- The trading halt will remain until either the announcement is released or trading begins on 25 June 2024.
- The company made the request to maintain an orderly market and ensure the market is fully informed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omega Oil & Gas Limited (OMA) ORDINARY FULLY PAID |
Energy |
$284 |
Commercial Potential of Canyon Sandstone Confirmed
|
26 Aug 2025 9:11AM |
$0.310 |
$0.525 |
risen by
69.35%
|
|
OMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Omega Oil & Gas Limited confirmed commercial potential of Canyon Sandstone at ATP 2037.
- Namoi-1 well data showed gas-saturated reservoir intervals.
- Reservoir can deliver commercial gas rates based on flow and pressure data.
- Pressure analysis points to a large connected gas resource.
- Results validate Omega's exploration model and de-risk the asset.
- The project can significantly contribute to east coast gas supply.
- Omega to pursue further testing and next phase appraisal planning.
- The announcement highlights progress toward resource development and value creation for stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,445 |
Corporate Governance Statement
|
26 Aug 2025 9:11AM |
$8.350 |
$7.100 |
fallen by
14.97%
|
|
| Caprice Resources Limited (CRS) ORDINARY FULLY PAID |
Materials |
$78 |
High Resolution Aeromag Survey Commenced in West Arunta
|
26 Aug 2025 9:11AM |
$0.085 |
$0.089 |
risen by
4.71%
|
|
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$31,094 |
Coles Sustainability Report 2025
|
26 Aug 2025 9:10AM |
$20.730 |
$23.150 |
risen by
11.67%
|
|
Call 1300 880 160
Start a chat
Schedule a call
